ObjectiveHealth Clinical Research - North Dayton

05/01/2026

Laughter is more than just a moment of joy, it’s powerful medicine. 😊
This World Laughter Day, our team is celebrating the simple, healing impact of a smile. In clinical research, we focus on advancing science and improving lives, but we never forget the human side of what we do.

A shared laugh can reduce stress, build connections, and brighten even the busiest day. Today, we encourage everyone, our staff, participants, and community, to take a moment to laugh, connect, and uplift one another.

Because better health isn’t just about treatments—it’s also about well-being, positivity, and moments of joy.

04/23/2026

Cirrhosis Isn’t Always About Alcohol

Many people are surprised to learn that cirrhosis can develop without alcohol use.

Conditions like nonalcoholic fatty liver disease (NAFLD/NASH), hepatitis B or C, autoimmune liver disease, and genetic conditions can all lead to cirrhosis.

✅ Raising awareness helps reduce stigma
✅ Early diagnosis can slow progression
✅ Liver health matters for everyone

If you or someone you love has liver disease, you’re not alone. 💙 For information about the clinical trials we conduct in this space, please call (937) 469-8713

04/22/2026

Are you between the ages of 50–64? You may be eligible to participate in an important COVID-19 vaccine research study.
Researchers are continuing to learn how vaccines protect different age groups and how immunity changes over time. Your participation could help improve future vaccines and protect communities.
✔️ Compensation may be available
✔️ Health monitoring included
✔️ Contribute to vital medical research
Participation is voluntary, and all study procedures follow strict safety guidelines.
Interested or want to learn more? Call us at 937-469-8713
Help make a difference—for yourself and others. 💙

04/20/2026

Are you struggling with weight and dealing with conditions like diabetes or high blood pressure? You’re not alone, and it might be time to take a closer look at your liver health.
Being overweight combined with conditions like:
✔️ Type 2 Diabetes
✔️ High Blood Pressure
✔️ High Cholesterol
✔️ High Triglycerides
These risk factors may increase your risk of Fatty Liver Disease (MASH).
The good news? You may qualify for clinical research studies that are exploring new ways to treat and manage this condition.
💡 Take the next step toward better health today.
📞 Call 855-460-8031 or click here to see if you qualify https://objective.health/contact/
Your health matters, don’t wait.

03/06/2026

🌟 Have you been struggling to improve your liver health?

You may be eligible to participate in the SYNCHRONY Histology clinical research study, which is exploring a potential investigational treatment for people living with NASH/MASH (a type of fatty liver disease).

🔬 This study is researching whether a once-weekly investigational medication may help slow or reverse liver scarring in adults diagnosed with or suspected of having NASH/MASH. Participants will receive study-related care from experienced medical professionals, and study visits, tests, and medications are provided at no cost.

✔️ You may qualify if you:
• Are between 18–80 years old
• Have been diagnosed with NASH/MASH or may have signs of it
• Have type 2 diabetes or other metabolic conditions

Participation is voluntary, and reimbursement for reasonable travel expenses may be available.

👉 Learn more and see if you may qualify today:
https://akerosynchronyprogram.com/

The SYNCHRONY Histology study is seeking participants for a clinical study for adults who are living with non-cirrhotic nonalcoholic steatohepatitis, or NASH.

03/04/2026

Help advance research for fatty liver disease!

Did you know that MASH (formerly known as NASH) is a chronic liver disease caused by fat buildup in the liver that can lead to inflammation and scarring (fibrosis)? It is most common in people who are obese and/or have Type 2 diabetes.

Researchers are studying a potential treatment through the ENLIGHTEN Fibrosis clinical trial and are looking for participants who may qualify.

If you or someone you know has been diagnosed with MASH/NASH with fibrosis, you may be eligible to take part in this important research.

👉 See if you qualify and learn more:
https://www.enlightenstudy.com/
Together, we can help improve the future of liver disease treatment.